Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Elliott

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Biochemistry|May 1, 1990
Slow binding inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductaseP Louis-Flamberg, C E Peishoff, D L Bryan, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 8, 1998
Nonpeptide endothelin receptor antagonists. XI. Pharmacological characterization of SB 234551, a high-affinity and selective nonpeptide ETA receptor antagonistE H Ohlstein, P Nambi, D W Hay, et al.
Veterinary Immunology and Immunopathology|January 1, 1990
T lymphocyte subset alterations following bluetongue virus infection in sheep and cattleJ A Ellis, A J Luedke, W C Davis, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1994
Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogsD P Brooks, P D dePalma, M Gellai, et al.
Pulmonary Pharmacology & Therapeutics|April 20, 1999
Effect of SB 217242 on hypoxia-induced cardiopulmonary changes in the high altitude-sensitive ratD C Underwood, S Bochnowicz, R R Osborn, et al.
Journal of Cardiovascular Pharmacology|May 22, 1998
Plasma- and cerebrospinal fluid-immunoreactive endothelin-1: effects of nonpeptide endothelin receptor antagonists with diverse affinity profiles for endothelin-A and endothelin-B receptorsR N Willette, C F Sauermelch, B L Storer, et al.
Circulation Research|July 1, 1994
A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670S A Douglas, C Louden, L M Vickery-Clark, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 1994
Tyr-129 is important to the peptide ligand affinity and selectivity of human endothelin type A receptorJ A Lee, J D Elliott, J A Sutiphong, et al.
Journal of Cardiovascular Pharmacology|May 22, 1998
Pharmacologic characterization of the novel, orally available endothelin-A--selective antagonist SB 247083S A Douglas, P Nambi, M Gellai, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1994
Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670E H Ohlstein, G R Beck, S A Douglas, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Biochemistry|May 1, 1990
Slow binding inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductaseP Louis-Flamberg, C E Peishoff, D L Bryan, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 8, 1998
Nonpeptide endothelin receptor antagonists. XI. Pharmacological characterization of SB 234551, a high-affinity and selective nonpeptide ETA receptor antagonistE H Ohlstein, P Nambi, D W Hay, et al.
Veterinary Immunology and Immunopathology|January 1, 1990
T lymphocyte subset alterations following bluetongue virus infection in sheep and cattleJ A Ellis, A J Luedke, W C Davis, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1994
Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogsD P Brooks, P D dePalma, M Gellai, et al.
Pulmonary Pharmacology & Therapeutics|April 20, 1999
Effect of SB 217242 on hypoxia-induced cardiopulmonary changes in the high altitude-sensitive ratD C Underwood, S Bochnowicz, R R Osborn, et al.
Journal of Cardiovascular Pharmacology|May 22, 1998
Plasma- and cerebrospinal fluid-immunoreactive endothelin-1: effects of nonpeptide endothelin receptor antagonists with diverse affinity profiles for endothelin-A and endothelin-B receptorsR N Willette, C F Sauermelch, B L Storer, et al.
Circulation Research|July 1, 1994
A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670S A Douglas, C Louden, L M Vickery-Clark, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 1994
Tyr-129 is important to the peptide ligand affinity and selectivity of human endothelin type A receptorJ A Lee, J D Elliott, J A Sutiphong, et al.
Journal of Cardiovascular Pharmacology|May 22, 1998
Pharmacologic characterization of the novel, orally available endothelin-A--selective antagonist SB 247083S A Douglas, P Nambi, M Gellai, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1994
Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670E H Ohlstein, G R Beck, S A Douglas, et al.
Pageof 5